Dr Reddys Laboratories (RDY) Net Income towards Common Stockholders Growth (5y) (2014 - 2023)
Dr Reddys Laboratories (RDY) Net Income towards Common Stockholders Growth (5y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.84 Bn | 9.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 20.87% |
| Mar 31, 2023 | 21.82% |
| Dec 31, 2022 | 21.60% |
| Sep 30, 2022 | -92.15% |
| Mar 31, 2021 | -3.71% |
| Sep 30, 2020 | -26.41% |
| Jun 30, 2020 | 6.26% |
| Sep 30, 2019 | -23.01% |
| Mar 31, 2019 | 0.43% |
| Dec 31, 2018 | -7.89% |
| Sep 30, 2018 | -6.89% |
| Jun 30, 2018 | -60.19% |
| Mar 31, 2018 | -65.29% |
| Dec 31, 2017 | -15.97% |
| Sep 30, 2017 | -11.51% |
| Dec 31, 2016 | -57.41% |
| Sep 30, 2016 | -62.08% |
| Mar 31, 2016 | 9.53% |
| Dec 31, 2015 | -5.04% |
| Sep 30, 2015 | 22.50% |